Ligand validation:4I9R

RET: RETINAL

RET is a Ligand Of Interest in 4I9R designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4I9R_RET_A_201	24%	19%	0.251	0.883	1.61	2.01	3	7	1	0	100%	0.9524
4YKM_RET_A_201	78%	38%	0.084	0.927	0.71	1.75	-	6	0	0	100%	0.9524
4YFQ_RET_A_201	70%	41%	0.1	0.917	0.77	1.58	-	4	0	0	100%	0.9524
4YKO_RET_B_201	62%	38%	0.1	0.89	0.64	1.82	-	8	0	0	100%	0.9524
4YBP_RET_A_201	55%	36%	0.139	0.908	0.8	1.78	-	7	1	0	100%	0.9524
4YGZ_RET_A_201	54%	40%	0.151	0.915	0.73	1.64	-	5	0	0	100%	0.9524
7XJE_RET_A_301	99%	7%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
7XJC_RET_A_301	97%	11%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752
7XJD_RET_A_301	97%	11%	0.06	0.972	1.93	2.42	2	14	0	0	100%	0.9524
5ZIN_RET_A_250	96%	7%	0.054	0.964	2.81	2.16	4	10	0	0	100%	0.9524
6TK7_RET_A_301	96%	62%	0.059	0.967	0.85	0.59	1	-	1	0	100%	0.9524

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.